Jim Simons Nemaura Medical Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.78 - $4.66 $143,171 - $176,502	-37,876 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.12 - $6.35 $200,330 - $308,762	-48,624 Reduced 56.21%	37,876 $173,000
Q3 2021 Nov 12, 2021	BUY	$5.76 - $9.95 $332,202 - $573,856	57,674 Added 200.08%	86,500 $520,000
Q2 2021 Aug 13, 2021	BUY	$4.7 - $16.7 $135,482 - $481,394	28,826 New	28,826 $298,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.